![John Houston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Houston
Direttore/Membro del Consiglio presso
ARVINAS, INC.
Patrimonio netto: 9 M $ in data 31/05/2026
Profilo
John G. Houston ricopre la posizione di presidente, amministratore delegato e direttore di Arvinas, Inc. e presidente, amministratore delegato e direttore di Arvinas Operations, Inc. (una consociata di Arvinas, Inc.). Fa anche parte del consiglio di NextCure, Inc., Cybrexa, Inc. e Oerth Bio LLC. John G. Houston ha occupato in precedenza la posizione di vicepresidente senior-Specialty Discovery alla Bristol Myers Squibb Co. e Head-Lead Discovery Unit alla GlaxoSmithKline Research & Development Ltd. Ha ricevuto un dottorato dall'Università di Glasgow e un dottorato dalla Heriot-Watt University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ARVINAS, INC. 1,54% | 31/03/2026 | 992.689 ( 1,54% ) | 9 M $ | 31/05/2026 |
NEXTCURE, INC. -.--% | 22/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di John Houston
| Società | Posizione | Inizio |
|---|---|---|
| ARVINAS, INC. | Direttore/Membro del Consiglio | 12/02/2026 |
| NEXTCURE, INC. | Direttore/Membro del Consiglio | 10/09/2020 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Amministratore Delegato | 21/09/2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Direttore/Membro del Consiglio | 03/09/2019 |
Oerth Bio LLC
 Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Direttore/Membro del Consiglio | 01/06/2019 |
Connecticut United for Research Excellence, Inc.
 Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Direttore/Membro del Consiglio | 01/12/2015 |
Bioct Innovation Commons | Direttore/Membro del Consiglio | 01/12/2015 |
Precedenti posizioni note di John Houston
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/08/2016 |
GlaxoSmithKline Research & Development Ltd.
 GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Corporate Officer/Principal | - |
Formazione di John Houston
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
63
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
 Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Connecticut United for Research Excellence, Inc.
Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Commercial Services |
GlaxoSmithKline Research & Development Ltd.
GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Commercial Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Bioct Innovation Commons | Finance |
